Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Cell Death and Differentiation
|
January 17, 2009
Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis
E M Michalak, E S Jansen, L Happo, et al.
Mucosal Immunology
|
September 20, 2012
Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors
C C Bain, C L Scott, H Uronen-Hansson, et al.
Cell Death and Differentiation
|
July 18, 2015
BCR-signaling-induced cell death demonstrates dependency on multiple BH3-only proteins in a murine model of B-cell lymphoma
M J Carter, K L Cox, S J Blakemore, et al.
Mucosal Immunology
|
August 21, 2014
CCR2(+)CD103(-) intestinal dendritic cells develop from DC-committed precursors and induce interleukin-17 production by T cells
C L Scott, C C Bain, P B Wright, et al.
Mucosal Immunology
|
May 23, 2014
Lymph-borne CD8α+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells
V Cerovic, S A Houston, J Westlund, et al.
Mucosal Immunology
|
May 9, 2013
Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid
J C J Martin, G Bériou, M Heslan, et al.
Cell
|
September 18, 1999
SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine
W S Alexander, R Starr, J E Fenner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 2, 2020
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
R E Miller, A Leary, C L Scott, et al.
Gynecologic Oncology
|
May 27, 2020
The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients
M Gleeson, M Kentwell, B Meiser, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 2, 2007
Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma
R K Lindemann, A Newbold, K F Whitecross, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Cell Death and Differentiation
|
January 17, 2009
Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis
E M Michalak, E S Jansen, L Happo, et al.
Mucosal Immunology
|
September 20, 2012
Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors
C C Bain, C L Scott, H Uronen-Hansson, et al.
Cell Death and Differentiation
|
July 18, 2015
BCR-signaling-induced cell death demonstrates dependency on multiple BH3-only proteins in a murine model of B-cell lymphoma
M J Carter, K L Cox, S J Blakemore, et al.
Mucosal Immunology
|
August 21, 2014
CCR2(+)CD103(-) intestinal dendritic cells develop from DC-committed precursors and induce interleukin-17 production by T cells
C L Scott, C C Bain, P B Wright, et al.
Mucosal Immunology
|
May 23, 2014
Lymph-borne CD8α+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells
V Cerovic, S A Houston, J Westlund, et al.
Mucosal Immunology
|
May 9, 2013
Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid
J C J Martin, G Bériou, M Heslan, et al.
Cell
|
September 18, 1999
SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine
W S Alexander, R Starr, J E Fenner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 2, 2020
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
R E Miller, A Leary, C L Scott, et al.
Gynecologic Oncology
|
May 27, 2020
The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients
M Gleeson, M Kentwell, B Meiser, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 2, 2007
Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma
R K Lindemann, A Newbold, K F Whitecross, et al.
Page
of 6